Medical Center Occupational Health Basics-Appendix 4

Appendix 4

Pdf Summary

This document outlines an acknowledgment and declination form for individuals with latent tuberculosis infection (LTBI) who choose to decline or postpone treatment. It confirms that the individual has a positive tuberculosis test (either skin or blood test such as QuantiFERON or TSpot.TB) and a negative chest X-ray for active TB, indicating exposure to TB and presence of LTBI.<br /><br />Key points include:<br /><br />- LTBI is non-communicable but can potentially develop into active TB, which is contagious and requires complex treatment. If untreated, active TB can be fatal.<br />- Treating LTBI with anti-TB medications significantly reduces the risk of progression to active TB.<br />- Symptoms of active TB, such as a persistent cough lasting over three weeks, coughing blood, night sweats, unexplained weight loss, or fevers, necessitate immediate medical attention and work cessation.<br />- The individual is informed about the benefits of LTBI treatment and the risks of not undergoing treatment, maintaining the option to seek treatment in the future if desired.<br /><br />The form requires signatures from the employee and occupational health staff, confirming understanding and receipt of information regarding the implications of declining or postponing LTBI treatment. This ensures all parties acknowledge the potential health risks involved and the individual's decision regarding their health management.

Keywords

latent tuberculosis infection

LTBI

tuberculosis test

QuantiFERON

TSpot.TB

active TB

anti-TB medications

treatment declination

occupational health

health management